Skip to Main Content Menu Search Site

Broad-Spectrum RNA Therapeutic for COVID-19 and Influenza

Immunostimulatory RNAs inhibit infection of multiple types of respiratory viruses, including SARS-CoV-2

Want to license this technology?

We are seeking a commercial partner with experience in RNA therapeutics and targeted delivery to help rapidly commercialize this technology.

Close menu